Lumature Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $113K | Sell |
1,394
-72
| -5% | -$5.82K | 0.07% | 188 |
|
|
2023
Q1 | $117K | Sell |
1,466
-570
| -28% | -$45.3K | 0.07% | 182 |
|
|
2022
Q4 | $138K | Sell |
2,036
-266
| -12% | -$18K | 0.08% | 173 |
|
|
2022
Q3 | $115K | Sell |
2,302
-260
| -10% | -$13K | 0.06% | 187 |
|
|
2022
Q2 | $143K | Sell |
2,562
-602
| -19% | -$33.6K | 0.06% | 192 |
|
|
2022
Q1 | $176K | Hold |
3,164
| – | – | 0.07% | 185 |
|
|
2021
Q4 | $177K | Sell |
3,164
-372
| -11% | -$20.8K | 0.07% | 149 |
|
|
2021
Q3 | $170K | Sell |
3,536
-598
| -14% | -$28.8K | 0.07% | 148 |
|
|
2021
Q2 | $173K | Sell |
4,134
-764
| -16% | -$32K | 0.07% | 150 |
|
|
2021
Q1 | $165K | Sell |
4,898
-11,854
| -71% | -$399K | 0.09% | 132 |
|
|
2020
Q4 | $585K | Buy |
+16,752
| New | +$585K | 0.55% | 52 |
|